Large American companies face market diminution and increased costs of production according to a new report by Innovest, a New York-based investment research firm. Innovest has issued a new report detailing potential corporate impacts of REACH wherein 11 companies out of 73 analyzed face specific risks. The report reviews exposure to potential regulatory action in Europe, management readiness, and strategic profit opportunities that may arise from the directive. To estimate financial exposure to regulatory impacts of REACH on "substances of very high concern", Innovest utilized the SIN list from ChemSec.

Innovest press release